Crispr Therapeutics shares tumble after significant earnings miss
On Friday, Stifel analysts adjusted their outlook on DoubleVerify (NYSE:DV) shares, reducing the price target to $20 from the previous $22, while continuing to endorse the stock with a Buy rating. Currently trading at $14.65, the company maintains a "GREAT" financial health score according to InvestingPro analysis. The revision follows DoubleVerify’s recent report of missed earnings and a downward guidance, attributed to ongoing client-specific issues.
DoubleVerify, a software platform for digital media measurement and analytics, has been affected by a group of six clients experiencing individual challenges that have led to reduced advertising expenditure. These issues were expected to ease in 2025, but a significant consumer packaged goods client, which spent over $20 million in 2024, has now opted for platform-native advertising solutions such as those offered by META. This move is part of the client’s extensive $3 billion restructuring plan, and DoubleVerify anticipates no revenue from this client in 2025.
Despite these setbacks, Stifel’s analysis suggests that DoubleVerify’s organic growth rate would have been in the range of 12.5-13.5% year-over-year, aligning with investor expectations that were modest prior to the earnings release. The company maintains impressive gross profit margins of 82.26% and boasts a perfect Piotroski Score of 9, indicating strong financial fundamentals. The confirmation of previously noted price increases for the company’s services provides some reassurance to Stifel that the market for verification companies is not engaged in a detrimental price competition.
In light of these developments, Stifel has maintained a positive outlook on DoubleVerify, albeit with adjusted financial estimates. The new target price of $20 reflects these recalibrated expectations while affirming the firm’s confidence in DoubleVerify’s long-term prospects. InvestingPro analysis suggests the stock is currently undervalued, with 12 additional exclusive insights available to subscribers. Access the comprehensive Pro Research Report for a deep dive into DoubleVerify’s financial health and growth potential.
In other recent news, DoubleVerify reported its fourth-quarter 2024 earnings, revealing a revenue of $191 million, which fell short of the forecasted $197 million. This represented an 11% year-over-year increase, contributing to a total annual revenue of $657 million, marking a 15% growth from the previous year. Despite the revenue miss, the company achieved a 33% adjusted EBITDA margin and a 33% increase in net cash from operating activities. Goldman Sachs downgraded DoubleVerify’s stock from Buy to Neutral, lowering the price target to $20 due to a challenging demand environment and persistent growth headwinds. Meanwhile, Canaccord Genuity maintained a Buy rating but reduced the price target to $26, citing underperformance in the fourth quarter. DoubleVerify has been active in strategic developments, launching new solutions for Meta (NASDAQ:META) and TikTok, and integrating Scibids, which saw a 50% year-over-year growth. The company also acquired RockerBox to enhance performance measurement capabilities, although the forward guidance for Q1 2025 projects a revenue of $151 million to $155 million, reflecting a cautious outlook.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.